ABIOMED, Inc. Product Pipeline Analysis

Global Markets Direct, May 2008, Pages: 53

Summary

This report is an insightful source for data, analysis and strategic insights into a ABIOMED, Inc.’s pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope
- Details of development stage by sector and equipment type.
- Pipeline products grouped by therapy area, development stage and trial phase.
- Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
- Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
- Product updates covering estimated approval dates and estimated launch dates.
- Descriptions of novel technologies relating to pipeline products of the company.
- Patents and patent applications covered for the product.
- News updates on key events relating to the product and its development.

Reason to buy
- A single source to fulfill competitor information relating to products in development.
- Identify pipeline products that are potential competitor to your product lines.
Understand a companys strategic position by accessing detailed independent intelligence on its product pipeline.
- Access clinical trial information to map trial results and plan targeted marketing activities.
- Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
- Identification of potential investment opportunities.
- Build up knowledge base for potential distribution and marketing partners.
- Helps avoid patent infringement.
- Timelines from concept to market lets you keep track of market potential build for a new product.
Assess a companys future growth by determining its pipeline depth, for probable acquisition opportunities.

1 3
1.1 List of Tables 7
1.2 List of Figures 8
2 Company Snapshot 9
2.1 Key Information 9
2.2 Company Overview 9
2.3 Financial Performance 9
2.4 Industry Outlook - Cardiovascular Devices 9
2.5 SWOT Snapshot 10
3 ABIOMED, Inc. Pipeline Products 11
3.1 ABIOMED, Inc. Product Pipeline Analysis 11
3.1.1 ABIOMED, Inc. Pipeline Products By Equipment Type 11
3.1.2 ABIOMED, Inc. Pipeline Products By Development Stage 11
3.1.3 ABIOMED, Inc. Pipeline Products By Therapy Area 11
3.1.4 ABIOMED, Inc. Pipeline Products By Clinical Trials 12
3.1.5 ABIOMED, Inc. Pipeline Products By News Summary 13
3.2 AbioCor II 14
3.2.1 Product Description 14
3.2.2 Product Status 14
3.2.3 Clinical Trials 14
3.2.4 Product Milestone 15
3.2.5 Product Patent Details 15
3.3 Impella 2.5 16
3.3.1 Product Description 16
3.3.2 Product Status 17
3.3.3 Clinical Trials 17
3.3.4 Product Milestone 20
3.4 Impella 5.0 21
3.4.1 Product Description 21
3.4.2 Product Status 21
3.4.3 Clinical Trials 21
3.4.4 Product Milestone 22
3.5 Impella Pediatric Pump 23
3.5.1 Product Description 23
3.5.2 Product Status 24
3.6 AB5000 Portable Circulatory Support Driver 24
3.6.1 Product Description 24
3.6.2 Product Status 24
3.6.3 Product Milestone 24
3.7 Impella Implantable 25
3.7.1 Product Description 25
3.7.2 Product Status 25
4 Business Description 26
4.1 Business Overview 26
4.2 Research, Development and Sale of Medical Devices 26
4.2.1 Overview 26
4.2.2 Financials 26
4.2.3 Market View 26
4.2.4 Key Strategies 27
4.3 Major Products and Services 27
4.3.1 Overview 27
5 History 28
6 Competitors 30
7 Key Employees 31
8 Key Employee Biographies 32
9 Company Statement 34
10 Locations And Subsidiaries 36
10.1 Head Office 36
10.2 Other Locations & Subsidiaries 36
11 Financial Deals Landscape 37
11.1 Acquisition 37
11.1.1 ABIOMED Acquires Impella Cardiosystems 37
11.2 IPO 38
11.2.1 Abiomed Completes Public Offering Of Common Stock 38
11.2.2 Abiomed Announces Secondary Offering 39
12 Recent Developments 41
12.1 Strategy and Business Planning 41
12.1.1 Dec 31, 2007: Abiomed Announces Expansion In European Markets 41
12.1.2 Dec 19, 2007: WorldHeart Enters Strategic Alliance With Abiomed 41
12.2 Financial Announcements 41
12.2.1 May 21, 2008: Abiomed Reports Q4 Fiscal 2008 Results 41
12.2.2 Feb 07, 2008: Abiomed Reports Q3 Fiscal 2008 Results 43
12.2.3 Nov 08, 2007: Abiomed Reports Q2 Fiscal 2008 Results 43
12.2.4 Aug 09, 2007: Abiomed Reports Q1 Fiscal 2008 Results 44
12.2.5 May 17, 2007: Abiomed Reports Q4 Fiscal 2007 Results 45
12.2.6 Apr 26, 2007: Abiomed Announces Partial Exercise Of Over-Allotment Option 46
12.2.7 Mar 27, 2007: Abiomed Closes Sale Of Common Stock In Public Offering 46
12.2.8 Feb 05, 2007: Abiomed Reports Q3 Fiscal 2007 Results 46
12.2.9 Feb 02, 2007: Abiomed Reports Q3 Fiscal 2006 Results 47
12.2.10 Nov 08, 2006: Abiomed Reports Q2 Fiscal 2007 Results 48
12.2.11 Aug 08, 2006: Abiomed Reports Q1 Fiscal 2007 Results 48
12.2.12 May 08, 2006: Abiomed Reports Q4 Fiscal 2006 Results 49
12.3 Other Significant Developments 50
12.3.1 May 31, 2007: Abiomed Appoints New Director 50
12.3.2 Jan 16, 2007: Abiomed Appoints New Board Member 50
12.3.3 Jan 09, 2006: Abiomed Appoints Lead Director Of Its Board 50
12.3.4 Dec 19, 2005: Abiomed Appoints New CFO 50
13 Appendix 51
13.1 Methodology 51
13.1.1 Coverage 51
13.1.2 Secondary Research 52
13.1.3 Primary Research 52
13.1.4 Expert Panel Validation 53
13.2 Contact Us 53
13.3 About us53
13.4 Disclaimer 53

1.1 List of Tables
Table 1: ABIOMED, Inc.,Key Facts, 2007 9
Table 2: ABIOMED, Inc. Pipeline Products by Equipment Type 11
Table 3: ABIOMED, Inc. Pipeline Products By Development Stage 11
Table 4: ABIOMED, Inc. Pipeline Products By Therapy Area 11
Table 5: ABIOMED, Inc. Pipeline Products By Clinical Trials 12
Table 6: ABIOMED, Inc. Pipeline Products By News Summaries 13
Table 7: ABIOMED, Inc., Key Employees, 2007 31
Table 8: ABIOMED, Inc., Subsidiaries 36

1.2 List of Figures
Figure 1: ABIOMED, Inc. Pipeline Products By Clinical Trials 12
Figure 2: ABIOMED, Inc. Pipeline Products By News Summary 13
Figure 3: Our Methodology51

The following companies are the major competitors of ABIOMED, Inc.:
Arrow International, Inc.
Medtronic, Inc.
Thoratec Corporation
SynCardia Systems, Inc.
World Heart Corporation
Berlin Heart GmbH
Ventracor Limited
Jarvik Heart, Inc.

Customers who bought this item also bought

• Top Five Global Electric Vehicle Companies: Performance, Strategies and Competitive Analysis
• Supplying Nissan
• General Motors Company - Strategies, Financial Outlook and Competitive Benchmark Analysis
• Ford Motor Company - Strategies, Financial Outlook and Competitive Benchmark Analysis
• Supplying Ford 2012
• Global Friction Products Market 2012-2016
• Global Automotive Head-up Display Market 2012-2016
• CarMax Inc
• Nissan Motor Co., Ltd - Strategies, Financial Outlook and Competitive Benchmark Analysis
• Toyota Motor Corporation - Strategies, Financial Outlook and Competitive Benchmark Analysis